/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Wave Life Sciences (WVE) generated about n/a in revenue and -$202 million in net income (a -478.3% net margin) over the trailing twelve months, growing at roughly 16.3% a year. Figures are from SEC filings; this is analysis, not investment advice.
Wave Life Sciences reported about -$202 million in net loss over the trailing twelve months, a net margin of roughly -478.3%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
Wave Life Sciences runs an operating margin of about -504.1%, a net margin of about -478.3%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
Wave Life Sciences's revenue has compounded at roughly 16.3% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside WVE's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 30 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 31 Jul 2026. How this is calculated.
Fiscal year ends Dec.